中国医药科学
中國醫藥科學
중국의약과학
CHINA MEDICINE AND PHARMACY
2013年
15期
79-80
,共2页
阿仑膦酸钠%骨质疏松%绝经后
阿崙膦痠鈉%骨質疏鬆%絕經後
아륜련산납%골질소송%절경후
Allen phosphonate sodium%Osteoporosis%Postmenopausal
目的观察阿仑膦酸钠对绝经后妇女骨质疏松症的治疗效果。方法从2009年3月~2012年6月,将本院收治的160例绝经后骨质疏松症患者随机分为两组各80例,分别为治疗组、观察组。两组均服用葡萄糖酸钙6 g/d,维生素D30.25μg/d,治疗组加服阿仑膦酸钠70 mg每周。治疗前后定期测定腰椎,髋骨骨密度值(BMD)。结果治疗3年后,腰椎,髋骨处骨密度值均显著提高。结论阿仑膦酸钠治疗绝经后妇女骨质疏松症疗效肯定。
目的觀察阿崙膦痠鈉對絕經後婦女骨質疏鬆癥的治療效果。方法從2009年3月~2012年6月,將本院收治的160例絕經後骨質疏鬆癥患者隨機分為兩組各80例,分彆為治療組、觀察組。兩組均服用葡萄糖痠鈣6 g/d,維生素D30.25μg/d,治療組加服阿崙膦痠鈉70 mg每週。治療前後定期測定腰椎,髖骨骨密度值(BMD)。結果治療3年後,腰椎,髖骨處骨密度值均顯著提高。結論阿崙膦痠鈉治療絕經後婦女骨質疏鬆癥療效肯定。
목적관찰아륜련산납대절경후부녀골질소송증적치료효과。방법종2009년3월~2012년6월,장본원수치적160례절경후골질소송증환자수궤분위량조각80례,분별위치료조、관찰조。량조균복용포도당산개6 g/d,유생소D30.25μg/d,치료조가복아륜련산납70 mg매주。치료전후정기측정요추,관골골밀도치(BMD)。결과치료3년후,요추,관골처골밀도치균현저제고。결론아륜련산납치료절경후부녀골질소송증료효긍정。
Objective To explore the effect of alendronate sodium on the postmenopausal osteoporosis.Methods From March 2009 to June 2012,160 poemrenopaueal Chinese women with established osteoporosis were randomly divided into two groups, treatment group(n=80) and control group(n=80). The patients in 2 group were both given Calcium gluconate 6mg every day and alfacaloidol 0.25μg once a day. 70 mg per week alendmnate were used to the patients in treatment group in addition. BMD in lumbar spine, total hip were measured. Results Alendronate therapy produced a significant increase in BMD at the lumber spine and total hip in 3 years. Conclusion Allen phosphonate sodium has a food elficacy for postmenopausal osteoporosis.